# § 520.1447   Milbemycin oxime, lufenuron, and praziquantel tablets.

(a) *Specifications.* Each tablet contains:


(1) 2.3 milligrams (mg) milbemycin oxime, 46 mg lufenuron, and 22.8 mg praziquantel;


(2) 5.75 mg milbemycin oxime, 115 mg lufenuron, and 57 mg praziquantel;


(3) 11.5 mg milbemycin oxime, 230 mg lufenuron, and 114 mg praziquantel; or


(4) 23 mg milbemycin oxime, 460 mg lufenuron, and 228 mg praziquantel.


(b) *Sponsor.* See No. 000061 in § 510.600(c) of this chapter.


(c) [Reserved]


(d) *Conditions of use*—(1) *Dogs*—(i) *Amount.* 0.5 mg milbemycin oxime, 10 mg lufenuron, and 5 mg of praziquantel per kilogram of body weight, once a month.


(ii) *Indications for use.* For the prevention of heartworm disease caused by *Dirofilaria immitis;* for the prevention and control of flea populations (*Ctenocephalides felis*); and for the treatment and control of adult roundworm (*Toxocara canis, Toxascaris leonina*), adult hookworm (*Ancylostoma caninum*), adult whipworm (*Trichuris vulpis*), and adult tapeworm (*Dipylidium caninum, Taenia pisiformis,**Echinococcus multilocularis,* and *E. granulosus*) infections in dogs and puppies 2 pounds of body weight or greater and 6 weeks of age and older.


(iii) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.


(2) [Reserved]



---

[N] [77 FR 4225, Jan. 27, 2012, as amended at 80 FR 18776, Apr. 8, 2015; 83 FR 13635, Mar. 30, 2018; 86 FR 13184, Mar. 8, 2021]




